Log in or subscribe to view full content. Article is also available for purchase the article in one of the available formats.
188549 items (188549 unread) in 47 feeds
World Health Organization
(225 unread)
Media
(145921 unread)
Bird Flu
(3037 unread)
Diabetes
(8383 unread)
Cholesterol
(3552 unread)
Cancer
(15070 unread)
HIV
(7233 unread)
Women
(3799 unread)
Men
(1329 unread)
Log in or subscribe to view full content. Article is also available for purchase the article in one of the available formats.
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia SAN DIEGO-- --Santarus, Inc.
When I was getting my degree in exercise science, one of the things we learned how to do is an exercise stress test with an ECG .
Forget the oysters and the champagne this Valentine's Day. If you want to keep your true love's heart beating strong, dark chocolate and red wine are the food and drink of love, said Susan Ofria, clinical nutrition manager at Gottlieb Memorial Hospital.
I'm aged 43 and have been taking simvastatin for seven months due to high cholesterol.
Most of us can recognize the difference between a brand name product and a non-brand named or generic product.
You have to know the high cholesterol symptoms as it is very important for you. Cholesterol is such a nutrition element, which is needed for the proper growth of a human body.
Q: High bad cholesterol, low good cholesterol, Off Lipitor due to severe loss of muscle, what foods or supplements should I take? Important: We hope you find this general health information helpful.
On February 2, 2012, Mylan Inc. announced the tentative U.S. Food and Drug Administration approval of Atorvastatin Calcium.
Merck & Co. swung to a fourth-quarter profit because of lower restructuring and other charges and higher sales of most of its key drugs.
THURSDAY, Feb. 2 -- Be wary of buying the cholesterol-lowering drugs known as statins on the Internet, British researchers say.
The bottom line is usually the one to watch. But not for AstraZeneca. On Thursday, the British drug maker announced a 7 per cent increase in earnings per share before exceptional items.
Merck & Co. Inc. is set to take such a hit in the second half of 2012. and Lilly, which reported steep declines in their fourth-quarter profits, experienced the initial impact from generics since they lost U.S. patent protection on several of their top-selling treatments.
Generic drugmaker Mylan Inc. said Thursday that the Food and Drug Administration tentatively approved several pill sizes of the company's generic version of cholesterol fighter Lipitor, the world's top-selling drug.
February is American Heart Month. For many years doctors and nutritionists have preached to cut red meat from the diet to improve heart health, but now new research shows that a moderate amount of lean beef is not only acceptable, but actually beneficial.
For the past several years, drug industry experts have spoken in terms of the "patent cliff," the period when the patents covering several blockbuster drugs are set to expire, thus leaving their manufacturers with a big, gaping hole in their revenues as those drugs face competition from generics.
More News in Brief: CT-Scan Dye Can Affect Thyroid; Sex Called Safe for Most Heart Patients; Safety of New Blood Thinner Gets a Closer Look Osteoporosis is a disease that causes bones to become "thin" . It can lead to hip fractures and spine fractures in elderly people.
Research from The Cancer Institute of New Jersey on the FDA-approved drugs Celebrex A and Lipitor A -- used respectively for arthritis pain and lowering cholesterol -- shows that these drugs are well tolerated in the treatment of recurrent prostate cancer .
Pfizer Inc., issuing its first financial report since losing patent protection on blockbuster cholesterol drug Lipitor, said today that adjusted earnings in the fourth quarter rose 6 percent.
Doctors are more likely to give cholesterol drugs known as statins to men. But a new study, published in the Jan.
PROFIT DIVE: Drugmaker Pfizer's fourth-quarter net income fell by half, to $1.44 billion, or 19 cents per share, because of charges and new generic competition for Lipitor, the blockbuster cholesterol-lowering drug.
Drugmaker Merck & Co., the world's third-biggest drugmaker by revenue and a Dow component, will tout recent drug approvals and progress on creating new drugs when it reports its fourth-quarter results before the stock market opens Thursday.
Pfizer Inc. said Tuesday that its fourth-quarter profit fell by half due to one-time charges and a drop in U.S. revenue, which was hurt by blockbuster cholesterol drug Lipitor losing patent protection.
A view of the Belgian headquarters of U.S. pharmaceutical giant Pfizer, in Brussels in this January 23, 2007 file photo.
Pfizer Inc.'s fourth-quarter profit fell by half due to one-time charges and a drop in U.S. revenue, which was hurt by blockbuster cholesterol drug Lipitor losing patent protection.
Dear Dr. Donohue: I am a 69-year-old woman and take simvastatin and alendronate.
MONDAY, Jan. 30 -- Cholesterol-lowering drugs known as statins are equally effective in men and women, a new study finds.
Both companies have to grapple with the expiration this year of patents on their largest products.
When one reads the above statement, moonshine may be the first thing that comes to mind, prompting them to ask, "Why would a Registered Dietitian suggest moonshine for breakfast?" White lighting was a brand of cider brewed by Scottish Courage in the UK from the early 1900s until 2009.
TRENTON, N.J. — Pfizer Inc., which reports fourth-quarter results before the stock market opens Tuesday, will tout two recent drug approvals, discuss a couple of other drugs awaiting approval and outline its revenue prospects now that it has generic competition to cholesterol blockbuster Lipitor.
It combines the anti-hyperglycemic drug sitagliptin with the antilipid drug simvastatin .
Pfizer's Inlyta drug for patients with advanced kidney cancer got the nod from U.S. regulators on Friday, boosting the company's plans to offset plunging Lipitor sales.
Sharon Weems did something in 2009 that most Americans in her situation can't seem to manage: She lowered her cholesterol significantly, and without the help of medication.
Pharmacy-benefit manager Express Scripts Inc. will soon make an adjustment that raises out-of-pocket costs for some customers filling prescriptions of Pfizer Inc.'s cholesterol-lowering drug Lipitor, underscoring the drug maker's challenge of keeping sales high in the face of generic competition.
Pfizer is scheduled to report 4Q 2011 earnings before the opening bell on Tuesday, January 31.
If you have diabetes, there are many ways to guard your health. Your efforts will help to control diabetes.
Simvastatin is a drug marketed under the brand name of Zocor by Merck & Co.A Zocor and its generics are used to regulate high cholesterol in those who cannot control their cholesterol level through diet and exercise alone.
US officials sought a "groundbreaking" injunction Wednesday against Indian pharmaceutical giant Ranbaxy, saying the maker of the first generic version of a cholesterol-lowering drug has failed to meet US safety guidelines.
Abbott Laboratories, the health-care company that plans to spin off its drug business, fell the most in two months after reporting fourth-quarter sales that came in below analyst estimates.
In SHARP, VYTORIN 10/20 mg lowered LDL cholesterol in patients with moderate to severe chronic kidney disease , and major vascular events were reduced in the treatment group compared to placebo.
Merck said the U.S. health regulator approved an updated label for its cholesterol treatment Vytorin to show that the drug effectively lowered bad cholesterol in patients with a kidney disease, and reduced the risk of vascular events.
The Nurse Practitioner: The American Journal of Primary Health Care February 2012 Volume 37 Number 2 Pages 56 - 56 The FDA notified healthcare professionals that the cholesterol-lowering medication fenofibric acid may not lower a patient's risk of myocardial infarction or stroke.
Pfizer Inc. 's strategy to keep its market share of cholesterol pill Lipitor may boost revenue without aiding profit, said the chief executive officer of Watson Pharmaceuticals Inc.
Andres is a man with early onset Alzheimer's disease . He is being evaluated for possible inclusion in a drug study when he develops bloody vomiting .
For breast cancer patients with a p53 genetic mutation may someday start taking statins -- drugs that lower cholesterol -- to help fight their disease.
When patents expire on profitable brand-name prescription drugs, patients and their insurance companies usually both catch a break on the price as generic manufacturers move in with cheaper versions of the same drug.
Grapefruit is a superstar among superfoods . Just one grapefruit packs more than 100 percent of the daily recommended serving of Vitamin C. Additionally, lycopene, the pigment that gives grapefruit its pink color, is linked to protection against heart disease, breast cancer, and prostate cancer, and it's been shown to help lower your "bad" LDL ... (more)
Watson Pharmaceuticals Inc. added another drug to its list of generic launches as it announced the launch of Vestura, the generic version of Bayer 's oral contraceptive, Yaz.
WHAT IT MEANS AND WHY IT'S IMPORTANT - One analysis report after another seems to confirm that the generic drug market is in for a huge shift as the number of blockbuster drugs losing patent protection is set to dwindle over the next several years.
Pfizer Inc. is the world's largest biopharmaceutical company. The company provides healthcare and drug products and services through two segments: biopharmaceutical segment and diversified segment.